BioSpace News Archive

Pharm Country

Boehringer Ingelheim and Lilly announce Tradjenta’s CARMELINA® cardiovascular outcome trial meets primary endpoint

Study supports long-term cardiovascular safety of Tradjenta® (linagliptin) in adults with type 2 diabetes

July 19, 2018
·
12 min read
Business

Leafbuyer Technologies Inc. Continues Strong Sales Growth

The company has announced a 50% sales increase from 4th Quarter 2017 compared to 4th Quarter 2018. June 2018 was the strongest sales growth in company history

July 19, 2018
·
1 min read
Business

GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination With a Multi-Billion Dollar Oncology Drug

GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA) announced today a Material Transfer Agreement (MTA) between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center, University of Minnesota.

July 19, 2018
·
4 min read
Business

Eyecarrot Secures Distribution Deal With Australasia’s Leading Behavioral Optometric Organization ACBO (‘Australasian College of Behavioural Optometrists’)

Eyecarrot Innovations Corp is pleased to announce it has secured a distribution deal with the leading Australasian Behavioural Optometric group ACBO

July 19, 2018
·
3 min read
BioForest

SiteOne Therapeutics to Present Research Findings for Selective Small Molecule Nav1.7 Inhibitors at the 2018 World Congress on Pain

SiteOne Anticipates Filing IND for Lead Candidate by Year-End 2018

July 19, 2018
·
2 min read
Business

Haemonetics Sets Date for Publishing First Quarter Fiscal 2019 Results: August 7, 2018

Haemonetics Corporation announced that the Company intends to publish first quarter fiscal 2019 financial results at 6:00 am EST on Tuesday, August 7, 2018.

July 19, 2018
·
1 min read
Business

Enzyvant Announces Collaboration with PerkinElmer to Enable Diagnostic Testing for Farber Disease

Enzyvant announced that it has formed a collaboration with PerkinElmer Genomics, a global genomic testing company.

July 19, 2018
·
2 min read
Business

VA and IBM Watson Health Extend Partnership to Support Veterans With Cancer

The U.S. Department of Veterans Affairs (VA) and IBM Watson Health (NYSE: IBM) announced the extension of a public-private partnership to apply artificial intelligence (AI) to help interpret cancer data in the treatment of Veteran patients.

July 19, 2018
·
2 min read
Drug Development

Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Doses First Patient in Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™

Study to evaluate Oral KORSUVA (CR845/difelikefalin) for the Treatment of Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients

July 19, 2018
·
5 min read
Drug Development

Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration

Allergan plc, a leading global pharmaceutical company and Molecular Partners, a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, today announced the release of two positive clinical trials.

July 19, 2018
·
10 min read